Fluopyram Patent Landscape Analysis

Developed by Bayer and commercialised through the Luna® and Velum® brands, fluopyram is a Group 7 SDHI carboxamide used as a foliar fungicide and as a nematicide and seed-treatment active.

The report retains 532 patent families across 265 consolidated owner groups. Combination development is the largest and most competitive layer, comprising 292 families and naming 112 partner actives. The upstream estate includes 141 families across compound, crystal form and process and intermediates, with 56 single-active formulation families.

A total of 288 families have a grant or national pending reading, while 22 live families reach their nominal term within five years. Three hundred seventy-two families are held by China-based applicants across 217 China-based owner groups—highlighting both the continuing density of protection and the approaching expiry of selected families.

This 131-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, followed by a complete directory of all 265 owner groups. Detailed patent tables identify holder, parent filing, claimed subject matter, priority, family members, status and term for every retained family.

Not a freedom-to-operate opinion.